BetterLife Pharma Inc.
BETRF
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.28M
Close$
$-0.00
102.3% downside
Current Fair Value
102.3% downsideOvervalued by 102.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $41.28 Million |
|---|---|
| Enterprise Value | $42.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.22 |
| Outstanding Shares | 162,322,501 |
Return
| Return on Equity | 32.03% |
|---|---|
| Return on Assets | -171.28% |
| Return on Invested Capital | 33.75% |
Valuation & Multiples
| P/E Ratio | -11.59 |
|---|---|
| PEG | -3.55 |
| Price to Sales | - |
| Price to Book Ratio | -0.19 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -16.62 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BetterLife Pharma Inc.
4 employees
CEO: Ahmad Doroudian BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary ...